EP1412372A4 - Endogenous and non-endogenous versions of human g protein-coupled receptors - Google Patents

Endogenous and non-endogenous versions of human g protein-coupled receptors

Info

Publication number
EP1412372A4
EP1412372A4 EP02717500A EP02717500A EP1412372A4 EP 1412372 A4 EP1412372 A4 EP 1412372A4 EP 02717500 A EP02717500 A EP 02717500A EP 02717500 A EP02717500 A EP 02717500A EP 1412372 A4 EP1412372 A4 EP 1412372A4
Authority
EP
European Patent Office
Prior art keywords
endogenous
protein
human
coupled receptors
versions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02717500A
Other languages
German (de)
French (fr)
Other versions
EP1412372A2 (en
Inventor
Chen W Liaw
Derek T Chalmers
Dominic P Behan
Dominique Maciejewski-Lenior
James N Leonard
I-Lin Lin
Daniel Ortuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arena Pharmaceuticals Inc
Original Assignee
Arena Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arena Pharmaceuticals Inc filed Critical Arena Pharmaceuticals Inc
Publication of EP1412372A2 publication Critical patent/EP1412372A2/en
Publication of EP1412372A4 publication Critical patent/EP1412372A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
EP02717500A 2001-02-26 2002-02-26 Endogenous and non-endogenous versions of human g protein-coupled receptors Withdrawn EP1412372A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27191301P 2001-02-26 2001-02-26
US271913P 2001-02-26
PCT/US2002/005625 WO2002068600A2 (en) 2001-02-26 2002-02-26 Endogenous and non-endogenous versions of human g protein-coupled receptors

Publications (2)

Publication Number Publication Date
EP1412372A2 EP1412372A2 (en) 2004-04-28
EP1412372A4 true EP1412372A4 (en) 2005-08-24

Family

ID=23037612

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02717500A Withdrawn EP1412372A4 (en) 2001-02-26 2002-02-26 Endogenous and non-endogenous versions of human g protein-coupled receptors

Country Status (5)

Country Link
EP (1) EP1412372A4 (en)
JP (1) JP2004526441A (en)
CN (1) CN1516706A (en)
CA (1) CA2439383A1 (en)
WO (1) WO2002068600A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115375B2 (en) 2000-11-14 2006-10-03 Bristol-Myers Squibb Methods of diagnosing renal tumors by determining the expression level of RNA encoding the HGPRBMY18 polypeptide
WO2004013638A1 (en) * 2002-07-31 2004-02-12 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 45 (gpr45)
WO2004013637A1 (en) * 2002-08-01 2004-02-12 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37)
DE10254601A1 (en) * 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Gene products differentially expressed in tumors and their use
CA2519230A1 (en) * 2003-03-17 2004-09-30 Arena Pharmaceuticals, Inc. Modulators of the g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders
DE602004023493D1 (en) * 2003-04-23 2009-11-19 Takeda Pharmaceutical NEW SCREENING PROCEDURE
JP4533655B2 (en) * 2003-04-23 2010-09-01 武田薬品工業株式会社 New screening method
WO2005059546A2 (en) * 2003-12-12 2005-06-30 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 35 (gpr35)
DE102004024617A1 (en) * 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
WO2006005588A1 (en) * 2004-07-12 2006-01-19 Geneprot, Inc. Polypeptide species useful for the treatment of neurological disorders
US7892755B2 (en) 2004-08-30 2011-02-22 Takeda Pharmaceutical Company Limited Screening method
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
CN103641908A (en) 2007-03-22 2014-03-19 赫普泰雅治疗有限公司 Mutant GPCR proteins and methods for selecting them
GB0724051D0 (en) 2007-12-08 2008-01-16 Medical Res Council Mutant proteins and methods for producing them
GB0724860D0 (en) 2007-12-20 2008-01-30 Heptares Therapeutics Ltd Screening
GB0802474D0 (en) 2008-02-11 2008-03-19 Heptares Therapeutics Ltd Mutant proteins and methods for selecting them
GB0910725D0 (en) 2009-06-22 2009-08-05 Heptares Therapeutics Ltd Mutant proteins and methods for producing them
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
KR102643443B1 (en) 2012-11-13 2024-03-06 비온테크 에스이 Agents for treatment of claudin expressing cancer diseases
GB201601690D0 (en) 2016-01-29 2016-03-16 Heptares Therapeutics Ltd G proteins

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000022129A1 (en) * 1998-10-13 2000-04-20 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human g protein-coupled receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE284972T1 (en) * 1996-09-24 2005-01-15 Cadus Pharmaceutical Corp METHODS AND COMPOSITIONS FOR IDENTIFYING RECEPTOR EFFECTORS

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000022129A1 (en) * 1998-10-13 2000-04-20 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human g protein-coupled receptors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MARAZZITI D ET AL: "CLONING OF GPR37, A GENE LOCATED ON CHROMOSOME 7 ENCODING A PUTATIVE G-PROTEIN-COUPLED PEPTIDE RECEPTOR, FROM A HUMAN FRONTAL BRAIN EST LIBRARY", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 45, 1997, pages 68 - 77, XP002936018, ISSN: 0888-7543 *

Also Published As

Publication number Publication date
EP1412372A2 (en) 2004-04-28
WO2002068600A2 (en) 2002-09-06
CN1516706A (en) 2004-07-28
JP2004526441A (en) 2004-09-02
WO2002068600A3 (en) 2004-02-26
CA2439383A1 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
IL149569A0 (en) Endogenous and non-endogenous versions of human g protein-coupled receptors
EP1412372A4 (en) Endogenous and non-endogenous versions of human g protein-coupled receptors
HK1079789A1 (en) Vasculostatic agents and methods of use thereof
HK1060728A1 (en) Antagonists of mcp-1 function and methods of use thereof
IL165280A0 (en) 4-Substituted imidazole-2-thiones and imidazol-2-ones as agpmosts of the alpha-2b and alpha-2c adrenergic receptors
AU1989002A (en) Endogenous and non-endogenous versions of human g protein-coupled receptors
AU2002257132A8 (en) Erbb interface peptidomimetics and methods of use thereof
NO20043907L (en) Partial and complete agonists of A1-adenosine receptors
AU2002351175A8 (en) Novel human g-protein coupled receptor, hgprbmy31, and variants and methods of use thereof
EP1461450A4 (en) T-bet compositions and methods of use thereof
AU2003285686A8 (en) Glycoisoforms of adiponectin and uses thereof
AU2001281791A1 (en) Regulation of human lgr4-like g protein-coupled receptor
AU2001260147A1 (en) Regulation of human rta-like g protein-coupled receptor
AU148927S (en) Section of an orthotic insert
AU2002326834A8 (en) Anopheles gambiae odorant receptors and genes
EP1424557A4 (en) Use of g protein-coupled receptor protein
AU2003220085A8 (en) Protein a compositions and methods of use
IL161608A0 (en) Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines
AU2001242485A1 (en) Regulation of human serotonin-like g protein-coupled receptor
AU6012901A (en) Regulation of human g protein-coupled receptor
AU2003210644A8 (en) Non-endogenous versions of human g protein-coupled receptor: fshr
AU2002226406A1 (en) Human g protein-coupled receptors and uses thereof
AU2002225030A1 (en) Regulation of human serotonin-like g protein-coupled receptor
AU2001274112A1 (en) Regulation of human rta-like g protein-coupled receptor
AU2002364149A8 (en) Novel human g-protein coupled receptor, hgprbmy34, and variants and methods of use thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030924

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/72 B

Ipc: 7C 12Q 1/68 B

Ipc: 7C 12N 15/63 B

Ipc: 7C 12N 15/09 B

Ipc: 7C 07K 14/705 B

Ipc: 7C 07H 21/04 A

A4 Supplementary search report drawn up and despatched

Effective date: 20050704

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050901